Trial intelligence / Profile preview

Odelepran in Alcohol Dependence

NCT00804570Phase 2Completed

Sponsor
Eli Lilly and Company
Start
Nov 2008
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of odelepran in alcohol dependence, sponsored by Eli Lilly and Company. Started Nov 2008; status: completed.

02

Drugs

odelepran
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00804570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00804570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call